Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vunakizumab in moderate-to-severe plaque psoriasis
NCT03463187Phase 2Completed
- Sponsor
- Hengrui
- Start
- Dec 2017
- Primary completion
- Aug 2020
- Modality
- Monoclonal Antibodies
- Countries
- 3
01
Overview
A Phase 2 trial of vunakizumab in plaque psoriasis, sponsored by Hengrui. Started Dec 2017; status: completed.
02
Drugs
vunakizumab
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT03463187.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03463187.